About | Abstracts | Lodging | Program | Registration | Sponsors | Venue

Agenda

The primary goal of the 20th International Symposium on NeuroVirology and 2025 Conference on HIV in the Central Nervous System is to bring together scientists and clinicians with interests in neurovirology and related fields, and to provide a venue that promotes collaboration and communication of findings in these fields.

Meeting Overview

This four-day Symposium will feature presentations from leading experts in these areas of interest below.

• NIH Focus Areas in Aging and HIV
  David Chang, PhD
  NIH Office of AIDS Research


• Virus-associated Chronic Conditions
  Tom Hobman, PhD
  University of Alberta


• Herpesviruses and Neurological Diseases
  Diego Restrepo, PhD
  University of Colorado School of Medicine


• New Technologies/Initiatives
  Dana Cairns, PhD
  Tufts University School of Engineering
  
  Christine Guzzo, PhD
  University of Toronto


• Global Neurovirology/Re-emerging Pathogens
  Vincent Racaniello, PhD
  Columbia University Medical Center
  
  Amy Rosenfeld, PhD
  Food and Drug Administration


• NeuroHIV and Co-Morbidities (including DOA)
  Ryan Ross, PhD
  Rush University Medical Center


• Exosomes-Biomarkers and Therapy
  Tsuneya Ikezu, MD, PhD
  Mayo Clinic


• Special Lecture: Artificial Intelligence in Research and Medicine
  Yuan Luo, PhD
  Northwestern Feinberg School of Medicine


• HIV Persistence, Therapy and Cure in the Brain
  Benjamin Chen, MD, PhD
  Icahn School of Medicine at Mt. Sinai


• Roles of Viruses in Aging and Dementias and Psychiatric Disorders
  Keenan Walker, PhD
  National Institute on Aging (NIA)
  National Institutes of Health (NIH)


• Multimodal Integrated Analysis and Assessment Development for NeuroHIV Outcomes (MIADD) - Brain health disorders (BHDs) affect a substantial proportion of people with HIV (PWH), including those who achieve viral suppression with antiretroviral therapy (ART). Unfortunately, there is significant heterogeneity in the clinical expression of BHDs among PWH, which hampers prevention and treatment efforts.
  
  This symposium introduces the MIAAD-NHIV project, a multi-national collaborative effort to leverage prior and ongoing NIH-sponsored research projects to better understand the heterogeneity of BHDs in PWH on suppressive ART using data from established cohorts and advanced analytic strategies, including machine learning and inferential methods. The results have potential to identify actionable mechanisms underlying complex clinical expressions of BHDs in PWH. The session will review the conceptual underpinnings of the project, the design and analytic strategy (including potential pitfalls and alternatives), and preliminary findings.